🔗 Share this article

An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Followers are urged to message these accounts directly for source information, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with numerous of participants share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers market the substance there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Experts Express Concerns

Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals administering products of uncertain source.

Some professionals said the demand for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Several content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Response and Content Removal

According to the social media company, the platform has removed problematic material and banned associated keywords and query recommendations. The company stated it was dedicated to keeping the service secure and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Investigations also discovered communities with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, populated with images of weight loss, glowing testimonials and detailed guides for preparing or injecting at home.

Within minutes of entering one community, a vendor posted WhatsApp details, where the majority of transactions occur. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about body mass, health issues or previous experience.

Item Information and Costs

Within these communities, messages show dark colored packages with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service stated it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering materials they can’t verify. Although the research behind this drug is valid, these digital products may not contain what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has previously encountered patients injured by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may subject patients to potentially significant health risks”.